Concepedia

Dominik Hainzl

DH

Statistics

Publications

29

Citations

1.8K

H-Index

19

Active since

1993

Affiliations

Roche (Switzerland)(Current)

University of Kassel

Novartis (United States)

Novartis (Switzerland)

Bial (Portugal)

Dominik Hainzl is an author at Roche (Switzerland) specializing in pharmacology, pharmacy, and medicinal chemistry.

Publications per year

1993–2023

29

Publications

29

Mechanisms for Selective Toxicity of Fipronil Insecticide and Its Sulfone Metabolite and Desulfinyl Photoproduct

Dominik Hainzl, Loretta M. Cole, John E. Casida · Chemical Research in Toxicology · 1998 · 373 citations

, , +15

Fipronil insecticide: Novel photochemical desulfinylation with retention of neurotoxicity

Dominik Hainzl, John E. Casida · Proceedings of the National Academy of Sciences · 1996 · 330 citations · Full text

, , +16

Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy

Simone Bonazzi, Eva d’Hennezel, Rohan E. J. Beckwith et al. · Cell chemical biology · 2023 · 156 citations · Full text

, , +14

Selective GlyT1 Inhibitors: Discovery of [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((<i>S</i>)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia

Emmanuel Pinard, Alexander Alanine, Daniela Alberati et al. · Journal of Medicinal Chemistry · 2010 · 134 citations · Full text

, , +13

Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia

Daniela Alberati, Jean‐Luc Moreau, Judith A. Lengyel et al. · Neuropharmacology · 2011 · 126 citations

, , +10

1–5 of 29